IRIDEX Corporation (IRIX)
USD 0.88
(-7.25%)
USD 0.88
(-7.25%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 24.91 Million USD | -0.58% |
| 2022 | 25.05 Million USD | -1.3% |
| 2021 | 25.38 Million USD | 139.44% |
| 2020 | 10.6 Million USD | -12.43% |
| 2019 | 12.1 Million USD | 3.39% |
| 2018 | 11.71 Million USD | 5.28% |
| 2017 | 11.12 Million USD | 23.82% |
| 2016 | 8.98 Million USD | 10.44% |
| 2015 | 8.13 Million USD | 0.66% |
| 2014 | 8.08 Million USD | 3.31% |
| 2013 | 7.82 Million USD | 11.65% |
| 2012 | 7 Million USD | -27.93% |
| 2011 | 9.72 Million USD | -0.71% |
| 2010 | 9.79 Million USD | -26.17% |
| 2009 | 13.26 Million USD | -19.5% |
| 2008 | 16.47 Million USD | -40.82% |
| 2007 | 27.84 Million USD | 247.18% |
| 2006 | 8.02 Million USD | 21.75% |
| 2005 | 6.58 Million USD | -9.89% |
| 2004 | 7.31 Million USD | 46.05% |
| 2003 | 5 Million USD | 22.85% |
| 2002 | 4.07 Million USD | 3.01% |
| 2001 | 3.95 Million USD | -12.6% |
| 2000 | 4.52 Million USD | -12.32% |
| 1999 | 5.16 Million USD | 106.44% |
| 1998 | 2.5 Million USD | -10.71% |
| 1997 | 2.8 Million USD | 27.27% |
| 1996 | 2.2 Million USD | 29.41% |
| 1995 | 1.7 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 27.6 Million USD | 10.8% |
| 2024 Q2 | 27 Million USD | -2.18% |
| 2023 Q4 | 24.91 Million USD | 8.87% |
| 2023 Q2 | 23.48 Million USD | -6.4% |
| 2023 Q1 | 25.09 Million USD | 0.15% |
| 2023 Q3 | 22.88 Million USD | -2.57% |
| 2023 FY | 24.91 Million USD | -0.58% |
| 2022 FY | 25.05 Million USD | -1.3% |
| 2022 Q1 | 26.69 Million USD | 5.16% |
| 2022 Q2 | 26.21 Million USD | -1.81% |
| 2022 Q3 | 26.88 Million USD | 2.56% |
| 2022 Q4 | 25.05 Million USD | -6.79% |
| 2021 Q1 | 23.91 Million USD | 125.5% |
| 2021 Q4 | 25.38 Million USD | 0.67% |
| 2021 FY | 25.38 Million USD | 139.44% |
| 2021 Q3 | 25.22 Million USD | 6.68% |
| 2021 Q2 | 23.64 Million USD | -1.13% |
| 2020 Q3 | 11.2 Million USD | 6.93% |
| 2020 FY | 10.6 Million USD | -12.43% |
| 2020 Q1 | 9.74 Million USD | -19.5% |
| 2020 Q2 | 10.48 Million USD | 7.53% |
| 2020 Q4 | 10.6 Million USD | -5.39% |
| 2019 Q2 | 12.85 Million USD | -2.78% |
| 2019 FY | 12.1 Million USD | 3.39% |
| 2019 Q4 | 12.1 Million USD | 1.15% |
| 2019 Q3 | 11.97 Million USD | -6.89% |
| 2019 Q1 | 13.22 Million USD | 12.92% |
| 2018 Q3 | 10.92 Million USD | 2.04% |
| 2018 Q4 | 11.71 Million USD | 7.17% |
| 2018 Q2 | 10.71 Million USD | 7.56% |
| 2018 FY | 11.71 Million USD | 5.28% |
| 2018 Q1 | 9.95 Million USD | -10.49% |
| 2017 Q1 | 7.58 Million USD | -15.58% |
| 2017 Q3 | 8.5 Million USD | 3.81% |
| 2017 Q4 | 11.12 Million USD | 30.75% |
| 2017 FY | 11.12 Million USD | 23.82% |
| 2017 Q2 | 8.19 Million USD | 8.07% |
| 2016 Q3 | 8.16 Million USD | -11.56% |
| 2016 Q2 | 9.22 Million USD | 12.91% |
| 2016 Q1 | 8.17 Million USD | 0.48% |
| 2016 FY | 8.98 Million USD | 10.44% |
| 2016 Q4 | 8.98 Million USD | 10.07% |
| 2015 Q4 | 8.13 Million USD | 3.88% |
| 2015 Q2 | 7.93 Million USD | -3.69% |
| 2015 Q3 | 7.83 Million USD | -1.32% |
| 2015 FY | 8.13 Million USD | 0.66% |
| 2015 Q1 | 8.24 Million USD | 1.95% |
| 2014 Q1 | 6.41 Million USD | -18.02% |
| 2014 Q2 | 6.54 Million USD | 2.06% |
| 2014 FY | 8.08 Million USD | 3.31% |
| 2014 Q3 | 6.95 Million USD | 6.31% |
| 2014 Q4 | 8.08 Million USD | 16.15% |
| 2013 Q3 | 6.96 Million USD | -2.58% |
| 2013 Q1 | 6.02 Million USD | -14.01% |
| 2013 Q2 | 7.14 Million USD | 18.57% |
| 2013 FY | 7.82 Million USD | 11.65% |
| 2013 Q4 | 7.82 Million USD | 12.4% |
| 2012 FY | 7 Million USD | -27.93% |
| 2012 Q4 | 7 Million USD | 4.93% |
| 2012 Q3 | 6.67 Million USD | 2.34% |
| 2012 Q2 | 6.52 Million USD | -2.0% |
| 2012 Q1 | 6.65 Million USD | -31.52% |
| 2011 FY | 9.72 Million USD | -0.71% |
| 2011 Q1 | 9.39 Million USD | -4.06% |
| 2011 Q4 | 9.72 Million USD | 4.74% |
| 2011 Q3 | 9.28 Million USD | 6.65% |
| 2011 Q2 | 8.7 Million USD | -7.35% |
| 2010 Q4 | 9.79 Million USD | 0.13% |
| 2010 Q2 | 9.27 Million USD | -5.13% |
| 2010 Q1 | 9.77 Million USD | -26.28% |
| 2010 Q3 | 9.78 Million USD | 5.42% |
| 2010 FY | 9.79 Million USD | -26.17% |
| 2009 Q4 | 13.26 Million USD | 2.05% |
| 2009 Q2 | 13.34 Million USD | -13.49% |
| 2009 FY | 13.26 Million USD | -19.5% |
| 2009 Q1 | 15.42 Million USD | -6.37% |
| 2009 Q3 | 12.99 Million USD | -2.61% |
| 2008 Q4 | 16.47 Million USD | -6.21% |
| 2008 Q2 | 20.46 Million USD | -7.05% |
| 2008 FY | 16.47 Million USD | -40.82% |
| 2008 Q1 | 22.01 Million USD | -20.95% |
| 2008 Q3 | 17.57 Million USD | -14.12% |
| 2007 Q3 | 26.1 Million USD | -19.71% |
| 2007 Q4 | 27.84 Million USD | 6.65% |
| 2007 FY | 27.84 Million USD | 247.18% |
| 2007 Q1 | 34.15 Million USD | 325.85% |
| 2007 Q2 | 32.51 Million USD | -4.8% |
| 2006 Q4 | 8.02 Million USD | 31.02% |
| 2006 FY | 8.02 Million USD | 21.75% |
| 2006 Q1 | 5.41 Million USD | -17.78% |
| 2006 Q2 | 5.88 Million USD | 8.64% |
| 2006 Q3 | 6.12 Million USD | 4.03% |
| 2005 FY | 6.58 Million USD | -9.89% |
| 2005 Q3 | 7.12 Million USD | -1.0% |
| 2005 Q4 | 6.58 Million USD | -7.52% |
| 2005 Q1 | 6.19 Million USD | -15.2% |
| 2005 Q2 | 7.19 Million USD | 16.07% |
| 2004 Q3 | 6.35 Million USD | 24.14% |
| 2004 Q4 | 7.31 Million USD | 15.08% |
| 2004 Q2 | 5.11 Million USD | 17.42% |
| 2004 Q1 | 4.35 Million USD | -12.93% |
| 2004 FY | 7.31 Million USD | 46.05% |
| 2003 Q3 | 4.3 Million USD | 2.62% |
| 2003 Q4 | 5 Million USD | 16.21% |
| 2003 Q2 | 4.19 Million USD | -4.55% |
| 2003 FY | 5 Million USD | 22.85% |
| 2003 Q1 | 4.39 Million USD | 7.93% |
| 2002 FY | 4.07 Million USD | 3.01% |
| 2002 Q1 | 2.9 Million USD | -26.68% |
| 2002 Q2 | 3.28 Million USD | 13.38% |
| 2002 Q3 | 3.85 Million USD | 17.15% |
| 2002 Q4 | 4.07 Million USD | 5.76% |
| 2001 Q2 | 3.47 Million USD | 8.14% |
| 2001 Q3 | 3.52 Million USD | 1.44% |
| 2001 Q4 | 3.95 Million USD | 12.07% |
| 2001 FY | 3.95 Million USD | -12.6% |
| 2001 Q1 | 3.21 Million USD | -28.91% |
| 2000 Q4 | 4.52 Million USD | -14.32% |
| 2000 Q1 | 4.84 Million USD | -6.06% |
| 2000 Q2 | 5.46 Million USD | 12.62% |
| 2000 Q3 | 5.28 Million USD | -3.28% |
| 2000 FY | 4.52 Million USD | -12.32% |
| 1999 Q1 | 2.8 Million USD | 12.0% |
| 1999 FY | 5.16 Million USD | 106.44% |
| 1999 Q2 | 3.2 Million USD | 14.29% |
| 1999 Q3 | 3.5 Million USD | 9.38% |
| 1999 Q4 | 5.16 Million USD | 47.46% |
| 1998 Q3 | 2.4 Million USD | -11.11% |
| 1998 FY | 2.5 Million USD | -10.71% |
| 1998 Q1 | 3.1 Million USD | 10.71% |
| 1998 Q2 | 2.7 Million USD | -12.9% |
| 1998 Q4 | 2.5 Million USD | 4.17% |
| 1997 FY | 2.8 Million USD | 27.27% |
| 1997 Q1 | 1.3 Million USD | -40.91% |
| 1997 Q2 | 2.5 Million USD | 92.31% |
| 1997 Q3 | 2.4 Million USD | -4.0% |
| 1997 Q4 | 2.8 Million USD | 16.67% |
| 1996 Q3 | 1.6 Million USD | 0.0% |
| 1996 Q4 | 2.2 Million USD | 37.5% |
| 1996 FY | 2.2 Million USD | 29.41% |
| 1996 Q2 | 1.6 Million USD | 0.0% |
| 1995 Q4 | 1.7 Million USD | 0.0% |
| 1995 FY | 1.7 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 51.391% |
| BrainsWay Ltd. | 15.31 Million USD | -62.688% |
| Cerus Corporation | 144.3 Million USD | 82.735% |
| Envoy Medical, Inc. | 9.4 Million USD | -164.986% |
| electroCore, Inc. | 8.94 Million USD | -178.524% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -366.38% |
| IceCure Medical Ltd | 4.24 Million USD | -486.626% |
| Inogen, Inc. | 121.38 Million USD | 79.475% |
| OrthoPediatrics Corp. | 72.56 Million USD | 65.665% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 15.777% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -682.981% |
| MaxCyte, Inc. | 36.1 Million USD | 31.0% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -1248.226% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -5758.244% |
| Orthofix Medical Inc. | 326.58 Million USD | 92.371% |
| PAVmed Inc | 57.13 Million USD | 56.396% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 2.156% |
| RxSight, Inc. | 22.18 Million USD | -12.286% |
| Sight Sciences, Inc. | 46.43 Million USD | 46.348% |
| SI-BONE, Inc. | 61.05 Million USD | 59.191% |
| TELA Bio, Inc. | 59.16 Million USD | 57.892% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 78.14% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -141.438% |
| Acutus Medical, Inc. | 54.83 Million USD | 54.569% |
| Talis Biomedical Corporation | 29.22 Million USD | 14.748% |
| Spectral AI, Inc. | 12.4 Million USD | -100.903% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -7.694% |
| CVRx, Inc. | 39.28 Million USD | 36.577% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -108.345% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -925.563% |
| Bioventus Inc. | 589.79 Million USD | 95.776% |
| Venus Concept Inc. | 107.1 Million USD | 76.738% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 51.776% |
| LivaNova PLC | 1.15 Billion USD | 97.837% |
| 908 Devices Inc. | 37.49 Million USD | 33.545% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 96.459% |
| Nemaura Medical Inc. | 26.37 Million USD | 5.548% |
| NeuroPace, Inc. | 86.99 Million USD | 71.362% |
| LENSAR, Inc. | 22.4 Million USD | -11.179% |
| Apyx Medical Corporation | 52.31 Million USD | 52.38% |
| Cutera, Inc. | 518.12 Million USD | 95.191% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 15.05% |
| BioSig Technologies, Inc. | 4.68 Million USD | -431.782% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 57.315% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -15.944% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 98.865% |
| Axonics, Inc. | 82.35 Million USD | 69.75% |
| Outset Medical, Inc. | 190.91 Million USD | 86.95% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 79.902% |
| IRadimed Corporation | 20.73 Million USD | -20.149% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -1388.292% |
| INVO Bioscience, Inc. | 19.99 Million USD | -24.601% |
| Telesis Bio, Inc. | 40.87 Million USD | 39.045% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 38.922% |
| Varex Imaging Corporation | 668.6 Million USD | 96.274% |
| Quipt Home Medical Corp. | 136.29 Million USD | 81.72% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -597.48% |
| Pulmonx Corporation | 60.63 Million USD | 58.912% |
| Dynatronics Corporation | 11.78 Million USD | -111.492% |
| Modular Medical, Inc. | 2.27 Million USD | -996.567% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -513.041% |
| Semler Scientific, Inc. | 6.27 Million USD | -297.352% |
| InMode Ltd. | 75.91 Million USD | 67.181% |
| Bruker Corporation | 2.83 Billion USD | 99.122% |
| Cytosorbents Corporation | 29.98 Million USD | 16.913% |
| DexCom, Inc. | 4.19 Billion USD | 99.406% |
| Align Technology, Inc. | 2.45 Billion USD | 98.985% |
| Viveve Medical, Inc. | 10.84 Million USD | -129.686% |
| ZimVie Inc. | 795.85 Million USD | 96.87% |
| Movano Inc. | 5.97 Million USD | -317.18% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 76.183% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -5758.244% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -108.345% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 96.101% |
| Profound Medical Corp. | 12.66 Million USD | -96.702% |
| Insulet Corporation | 1.85 Billion USD | 98.657% |
| enVVeno Medical Corporation | 2.43 Million USD | -923.162% |
| Surmodics, Inc. | 65.82 Million USD | 62.15% |
| iCAD, Inc. | 8 Million USD | -211.386% |
| Nuwellis, Inc. | 6.78 Million USD | -267.463% |
| Biotricity, Inc. | 35.91 Million USD | 30.639% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 88.83% |
| Aethlon Medical, Inc. | 2.47 Million USD | -904.739% |
| InspireMD, Inc. | 8.14 Million USD | -205.994% |
| PAVmed Inc. | 57.13 Million USD | 56.396% |
| BIOLASE, Inc. | 35.34 Million USD | 29.518% |
| Beyond Air, Inc. | 29.77 Million USD | 16.326% |
| FONAR Corporation | 57.45 Million USD | 56.639% |
| AxoGen, Inc. | 101.16 Million USD | 75.372% |
| Vivani Medical, Inc. | 25.03 Million USD | 0.487% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 71.623% |
| Inari Medical, Inc. | 209.32 Million USD | 88.098% |
| UFP Technologies, Inc. | 118.04 Million USD | 78.894% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -96.32% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -1039.805% |
| Tenon Medical, Inc. | 5.56 Million USD | -347.53% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1300.45% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -41.283% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.21% |
| Sintx Technologies, Inc. | 6.59 Million USD | -277.886% |
| NanoVibronix, Inc. | 2.68 Million USD | -827.55% |
| Quanterix Corporation | 78.08 Million USD | 68.093% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -597.48% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -410.01% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 97.615% |
| TransMedics Group, Inc. | 568.84 Million USD | 95.62% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -49.347% |
| NeuroMetrix, Inc. | 1.33 Million USD | -1768.843% |
| Hyperfine, Inc. | 9.8 Million USD | -154.224% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 90.044% |
| Biomerica, Inc. | 2.66 Million USD | -835.561% |
| Bone Biologics Corporation | 831.4 Thousand USD | -2896.625% |
| AVITA Medical, Inc. | 19.86 Million USD | -25.414% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -1162.31% |
| Silk Road Medical, Inc | 114.15 Million USD | 78.176% |